Healthy volunteer
Conditions
Interventions
Mydriatic (tropicamide 0.4%) eye drops before measurement
Sponsors
Kitasato University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The participant who - doesn't have ophthalmological diseases that affect blood flow measurement other than refractive error. - doesn't be diagnosed of cardiovascular disease or diabetes mellitus. - systolic blood pressure is less 150mmHg and diastolic blood pressure is less 90 mmHg. - doesn't take drugs that affect blood flow (Ca antagonists, alpha1 and beta1 blockers, PDE5 inhibitors). - has corrected visual acuity more than 0.8. - doesn't have refractive error exceeding +/-8D in spherical power or +/-2D in astigmatism. - doesn't have axial length of exceeding 26.5 mm. - has intraocular pressure of 21mmHg or less. - doesn't have history of refractive surgery.
Exclusion criteria
Exclusion criteria: The participant who - has ophthalmological diseases that affect blood flow measurement other than refractive error. - diagnosed of cardiovascular disease or diabetes mellitus. - systolic blood pressure exceeding 150 mmHg and diastolic blood pressure exceeding 90 mmHg. - Patients taking drugs that affect blood flow (Ca antagonists, alpha1 and beta1 blockers, PDE5 inhibitors). - has corrected visual acuity less than 0.8. - has refractive error exceeding +/-8D in spherical power or +/-2D in astigmatism. - has axial length exceeding 26.5 mm - has intraocular pressure of 21 mmHg or more - has patients with a history of refractive surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To measure ocular blood flow during eye movement in normal eyes and to compare with previously measured data in glaucoma patients | — |
Countries
Japan
Contacts
Public ContactKazunoei Hirasawa
Kitasato University School of Medicine Department of Ophthalmology
Outcome results
None listed